Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2002
12/27/2002WO2002102379A1 Sophoridine and use thereof as an analgesic
12/27/2002WO2002102373A1 Method for administration of cancer therapeutic
12/27/2002WO2002102365A1 Tricyclic terpenes of the family of abietic acid as rantes receptor ligands
12/27/2002WO2002102344A2 No-synthase inhibitor and use thereof
12/27/2002WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
12/27/2002WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002WO2002102312A2 Combination therapy of gamma-interferon and b cell specific antibodies
12/27/2002WO2002102311A2 Nanoparticles for treating targeted tissues and cells
12/27/2002WO2002102310A2 Proteins associated with cell growth, differentiation, and death
12/27/2002WO2002102309A2 Formulation of lymphokines and method of use thereof for local or bath local and systemic control of proliferative cell disorders
12/27/2002WO2002102307A2 Nucleoside vaccine adjuvants
12/27/2002WO2002102306A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002WO2002102299A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
12/27/2002WO2002102229A2 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002WO2002092565A3 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
12/27/2002WO2002085409A3 Methods and compositions for inducing an immune response to an antigen
12/27/2002WO2002083696A3 Novel cyclo azaphospha hydrocarbons
12/27/2002WO2002076946A3 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
12/27/2002WO2002074776A3 Highly purified and crystalline form of harringtonine
12/27/2002WO2002072077A3 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
12/27/2002WO2002070473A3 Carboxamide derivatives as therapeutic agents
12/27/2002WO2002056907A3 Molecular antigen array presenting amyloid beta
12/27/2002WO2002056874A3 Lipid-based nitric oxide donors
12/27/2002WO2002055087B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
12/27/2002WO2002053142A3 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
12/27/2002WO2002051994A3 Polypeptides
12/27/2002WO2002045746A3 Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
12/27/2002WO2002044157A3 Parb inhibitors
12/27/2002WO2002040545A3 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point
12/27/2002WO2002036750A3 T-cells specifically recognizing minor histocompatibility antigen(s) and uses thereof for eliminating target cells
12/27/2002WO2002018445A8 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
12/27/2002WO2002012467A3 Drug metabolizing enzymes
12/27/2002WO2002010379B1 Modified cea and uses thereof
12/27/2002WO2002004514A8 Compositions and methods for the therapy and diagnosis of lung cancer
12/27/2002WO2002002078A3 Improved liposomal camptothecins and uses thereof
12/27/2002WO2002000877A3 Antisense oligonucleotides to inhibit angiogenesis and/or metastasis
12/27/2002WO2001096390A3 Compositions and methods for the therapy and diagnosis of colon cancer
12/27/2002WO2001094587A3 Extracellular messengers
12/27/2002WO2001091699A3 Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways
12/27/2002WO2001087935A9 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
12/27/2002WO2001085986A3 Phosphatidyl inositol 3-kinase delta binding partner
12/27/2002WO2001085141A9 β-GLUCANS ENCAPSULATED IN LIPOSOMES
12/27/2002WO2001074903A9 Cd20/ige-receptor like molecules and uses thereof
12/27/2002WO2001052904A9 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides
12/27/2002WO2000052184A9 Anti-neoplastic compositions and uses thereof
12/27/2002CA2753372A1 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
12/27/2002CA2489019A1 Therapeutical vaccination
12/27/2002CA2465075A1 Hdac9 polypeptides and polynucleotides and uses thereof
12/27/2002CA2452255A1 2-adamantyl-4,6-diamino-1,2-dihydro-1-aryl-1,3,5-triazine derivatives as cell prolifiration inhibitors
12/27/2002CA2451874A1 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells
12/27/2002CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2450847A1 Novel compositions
12/27/2002CA2450845A1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
12/27/2002CA2450809A1 Methods for detecting and treating the early onset of aging-related conditions
12/27/2002CA2450793A1 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2450666A1 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002CA2450659A1 Tryptase inhibitors
12/27/2002CA2450590A1 Methods and compositions for inhibiting, preventing or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002CA2450159A1 Methods for modulating gap junctions
12/27/2002CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/27/2002CA2449977A1 Human growth hormone antagonists
12/27/2002CA2449898A1 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
12/27/2002CA2449288A1 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
12/27/2002CA2448971A1 Chimeric flavivirus vectors
12/27/2002CA2447624A1 Anti-tumour compound
12/27/2002CA2446285A1 Fibroblast growth factor and nucleic acid encoding same
12/27/2002CA2445731A1 Method and nucleic acids for the differentiation of prostate tumors
12/27/2002CA2430627A1 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
12/26/2002US20020198567 Electro-endocytotic therapy as a treatment modality of cancer
12/26/2002US20020198396 Oxime-group containing oestrone sulphatase inhibitors
12/26/2002US20020198379 Active compound from a sponge
12/26/2002US20020198264 Potentiating toxicity of 1,3-bis(chloroethyl)2-nitrosourea
12/26/2002US20020198256 Laulimalide microtubule stabilizing agents
12/26/2002US20020198254 Bactericides, fungicides and parasticides
12/26/2002US20020198248 Therapeutic methods and compositions involving isoflavones
12/26/2002US20020198240 Amino ceramide - like compounds and therapeutic methods of use
12/26/2002US20020198235 Use of benzothiopenes to treat and prevent prostate cancer
12/26/2002US20020198234 Identifying a patient suffering from fatigue arising from oncological condition, and administering to the patient a therapeutically effective amount of D-threo-methylphenidate free of 1-threo isomer
12/26/2002US20020198216 Novel farnesyl protein transferase inhibitors as antitumor agents
12/26/2002US20020198212 Optically active compounds
12/26/2002US20020198199 Such as 2-(2-(N-((4-aminoiminomethylphenyl)methyl)-3-(3-aminophenyl)-6-(N,N -dimethylhydrazino)-1-oxypyridinyl))acetami de which inhibit serine proteases for preventing and treating thrombotis
12/26/2002US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002US20020198177 Coenzyme Q and EPA
12/26/2002US20020198171 Administering to a hepatitis B infection patient an effective treatment amount of a 2'fluoro- beta -D-nucleoside or salts(containing purine or pyrimidine base)
12/26/2002US20020198164 A toxin gene is expressed under the transcriptional control of a human prostate-specific transcriptional regulatory sequence
12/26/2002US20020198160 Compositions and methods for enhancing the bioavailability of pharmaceutical agents
12/26/2002US20020198157 Galectins-carbohydrate conjugate complexes with required photophysical properties to damage cancer cells
12/26/2002US20020198156 Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor
12/26/2002US20020198153 Administering to an individual for tumor treatment a chemotherapeutically effective amount of antitumor agent carboplatin, and erythropoietin a hematocrit elevator which is administered befor or concurrently with antitumor agent
12/26/2002US20020198146 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts
12/26/2002US20020198143 B7-like polynucleotides, polypeptides, and antibodies
12/26/2002US20020198141 Molecular conjugates for use in treatment of cancer
12/26/2002US20020197692 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants
12/26/2002US20020197657 Apoptosis-related compounds and their use
12/26/2002US20020197654 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
12/26/2002US20020197609 Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression
12/26/2002US20020197306 Cationic lipid compositions targeting angiogenic endothelial cells
1 ... 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 ... 2211